Abstract
In Boron Neutron Capture Therapy (BNCT), the dominant dose delivered to the tumor is due to α- and 7 Li-charged particles resulting from neutron capture by 10B and is referred to as the boron dose. Boron dose is directly attributable to its concentration and also to the neutron energy spectrum because the neutron capture cress-section in boron has an 1/v dependence. The distribution of neutron energy at a given point is dictated by the incident neutron-energy distribution, the depth in tissue, and geometrical factors such as the beam’s size and patient’s dimensions. These factors can be accounted for using Monte Carlo simulations1. However, when using conventional dosimetry for BNCT, e.g., TLDs or ionization chambers, boron dose can only be estimated. Many of the issues on BNCT dosimetry were addressed in Ref. 2.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Yanch J.C., Zhou X-L., and Brownell G.L., A Monte Carlo investigation of the dosimetric properties of monoenergetic neutron beams for neutron capture therapy. Radiat. Res. 126, 1–20 (1991).
Zamenhof R.G., Solares G.R., and Harling O.K., Eds., Topics in Dosimetry & Treatment Planning for Neutron Capture Therapy. Advanced Medical Publishing, Madison, Wisconsin. (1994).
Svensson H., and Brahme A., Ferrous sulphate dosimetry for electrons: A re-evaluation. Acta Radiologica Oncology 18, 326–336 (1979).
Lawson R.C., and Porter D., The response of the ferrous sulfate dosemeter to neutrons. Phys. Med. Biol., 20, 420–430 (1975).
Fregene A.O., Calibration of the ferrous sulphate dosimeter by ionometric and calorimetric methods. Nature 19, 818–819 (1966).
Egusa S., Ishigure K., Tagawa S., Tabata Y., and Oshima K., Absorbed dose measurements in a mixed field of fast neutrons and gamma rays by the Fricke and ceric sulfate dosimeters. Radiat. Phys. Chem. 11, 129–134 (1978)
Ciesielski B., and Wielopolski L., Application of Fricke dosimetry for BNCT. Advances in Neutron Captre Therapy, Eds Soloway A.H., Barth R.F., and Carpenter D.E., Plenum Press, New York, p53–57, (1993).
Regulla D.F., and Deffner U., Dosimetry of ESR spectroscopy of alanine. Int. J. Appl. Radiat. Isot. 33, 1101–1114, (1982).
Schraube H., Weitzenegger E., Wieser A., and Regulla D.F., Fast neutron Response of alanine probes. Int. J. Appl. Radiat. Isot. 40, 941–944 (1989).
Wielopolski L., Maryanski M., Ciesielski B., Forman A., Reinstein L.E., and Meek A.G. Continous three dimensional dosimetry in tissue-equivalent phantoms using electron paramagnetic resonance in L-a alanine. Med. Phys. 14, 646–652 (1987).
Ciesielski B., and Wielopolski L., The effects of dose and radiation quality on the shape and power saturation of the EPR signal in alanine. Radiat. Res. 140, 105–111 (1994)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wielopolski, L., Ciesielski, B. (1996). Determination of Boron Dose for BNCT Using Fricke and EPR Dosimetry. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_66
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_66
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive